Noemi
0000-0001-7535-3861
9 papers found
Refreshing results…
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma
FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology
The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma
STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients
Missing publications? Search for publications with a matching author name.